kaileratherapeutics
The Senior Vice President, Program Leadership at Kailera is responsible for overseeing late-stage biopharmaceutical programs from Phase 3 through regulatory approval and launch readiness. This executive role drives integrated strategy, cross‑functional alignment, and decision‑making processes, ensuring programs meet timelines, risk, and compliance requirements while preparing for market launch.
Launching Soon
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for kaileratherapeutics.
171% above the average for this role
Executive Director, Global Program Manager
Kardigan
Vice President of Program Management
SAB
Vice President, Global Clinical Lead - Solid Tumor
BioLife Plasma Services
Vice President, Head of US Medical Affairs, Rare Disease
Ipsen
Vice President, Inflammatory and Immune Disease Biomarker Development
Apogee Therapeutics
Vice President, Quality
LeonaBio